Contact
Evvivax
Engineered Veterinary Vectored Immunotherapy and Vaccines
Via Castel Romano, 100 - Rome 00128 - Italy
VAT IT 13919361009-
This email address is being protected from spambots. You need JavaScript enabled to view it.
Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX
EVVIVAX is a spin-off of Takis Biotech, a company developing a number of Innovative Immunotherapies
EVVIVAX is at the forefront of nucleic-acid based therapies, process development, industrial scale production and clinical trial execution
EVVIVAX stems from new, European platform technologies, aims to offer novel therapeutic avenues to pet cancer patients, with the strong translational potential to complement current human Immune-Oncology approaches in the next future.
